Dr. Monish Raut elaborates on the role of HRCT as a valuable tool in confirming COVID-19 diagnosis and studying disease progression and severity among patients who test negative for RT-PCR initially. He also adds a note on the accuracy of the CO-RADS scoring system.

In a case series study that explored the association of COVID-19 and acute ischemic stroke, researchers at Emory University Hospital observed higher than expected rates of unexplained or "cryptogenic" strokes, as well as delays in stroke presentations or symptom recognition.

A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the virus from infecting human cells has been discovered by an international team of scientists led by the University of Bristol.

A new review article from Beth Israel Deaconess Medical Center (BIDMC) shows people who are biologically male are dying from COVID-19 at a higher rate than people who are biologically female.

A new study published in the open-access journal PLOS Medicine by Diana Buitrago-Garcia at the University of Bern, Switzerland and colleagues suggests that true asymptomatic cases of SARS-CoV-2 comprise a minority of infections.

Achieving herd immunity to COVID-19 is an impractical public health strategy, according to a new model developed by University of Georgia scientists. The study recently appeared in Proceedings of the National Academy of Sciences.

In a major study, researchers have found that having a lower level of zinc in the blood is associated with a poorer outcome in patients with COVID-19.

Researchers have found that many hospitalised patients with COVID-19 may face an increased risk for kidney damage or acute kidney injury (AKI), a dreaded complication for those suffering from infection.

Although people of any age can be infected with SARS-CoV-2, the virus that causes COVID-19, elderly patients face a higher risk of severity and death than younger patients. New research, comparing the immune response among age groups, may help explain why.

As the antimalarial drugs hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it's now more important than ever to have a thorough assessment of the safety of these medications.

Stroke patients who also have COVID-19 showed increased systemic inflammation, more serious stroke severity and a much higher rate of death, compared to stroke patients without coronavirus, warn researchers.

The Indian Council of Medical Research (ICMR) said that the efficacy of the COVID-19 vaccine in India is likely to remain between 50 to 100 percent, however, they are trying for 100 percent efficiency.

A team of researchers have shown that the virus initially suppresses the lung cells' ability to call in the help of the immune system with interferons to fight off the viral invaders and instead activates an inflammatory pathway called NFkB.

The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.